Maria-Christina Malinao

Statistics

Publications

Citations

264

H-Index

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Ajinomoto (United States)

Maria-Christina Malinao is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunopathology, molecular oncology, and antibody-drug conjugates.

Publications per year

2011–2023

Publications

Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease

Corinne Cayatte, Barbara Joyce-Shaikh, Félix V. Vega et al. · Clinical and Translational Gastroenterology · 2012 · 52 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Differential expression of monocyte/macrophage- selective markers in human idiopathic pulmonary fibrosis

B. L. Desai, Jeanine Mattson, Harman S. Paintal et al. · Experimental Lung Research · 2011 · 38 citations

Veterinary Medicine, Immunology, Pathology +17

Comparison of Analytical Methods for Antibody–Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP

Yutaka Matsuda, Verónica Robles, Maria-Christina Malinao et al. · Analytical Chemistry · 2019 · 35 citations

Pharmacy, Medicinal Chemistry, Pharmaceutical Analysis +17

Metabolism of an Oxime-Linked Antibody Drug Conjugate, AGS62P1, and Characterization of Its Identified Metabolite

Josh Snyder, Maria-Christina Malinao, Julien Dugal‐Tessier et al. · Molecular Pharmaceutics · 2018 · 34 citations

Medicine, Oncology, Pharmacology +17

Boronotyrosine, a Borylated Amino Acid Mimetic with Enhanced Solubility, Tumor Boron Delivery, and Retention for the Re-emerging Boron Neutron Capture Therapy Field

Arthur Raitano, Tioga Martin, Chunying Zhang et al. · Journal of Medicinal Chemistry · 2023 · 31 citations

Medicine, Cancer Biology, Oncology +11

1–5 of 9